CA2487907A1 - Immunogenic compositions comprising a xenogenic prostate protein p501s - Google Patents

Immunogenic compositions comprising a xenogenic prostate protein p501s Download PDF

Info

Publication number
CA2487907A1
CA2487907A1 CA002487907A CA2487907A CA2487907A1 CA 2487907 A1 CA2487907 A1 CA 2487907A1 CA 002487907 A CA002487907 A CA 002487907A CA 2487907 A CA2487907 A CA 2487907A CA 2487907 A1 CA2487907 A1 CA 2487907A1
Authority
CA
Canada
Prior art keywords
seq
polypeptide
xenogeneic
leu
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002487907A
Other languages
English (en)
French (fr)
Inventor
Jean-Pol Cassart
Catherine Marie Ghislaine Gerard
Paul A Hamblin
Remi M Palmantier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Glaxo Group Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0213364A external-priority patent/GB0213364D0/en
Priority claimed from GB0221689A external-priority patent/GB0221689D0/en
Application filed by Individual filed Critical Individual
Publication of CA2487907A1 publication Critical patent/CA2487907A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001193—Prostate associated antigens e.g. Prostate stem cell antigen [PSCA]; Prostate carcinoma tumor antigen [PCTA]; PAP or PSGR
    • A61K39/001194—Prostate specific antigen [PSA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/884—Vaccine for a specifically defined cancer prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002487907A 2002-06-11 2003-06-06 Immunogenic compositions comprising a xenogenic prostate protein p501s Abandoned CA2487907A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0213364A GB0213364D0 (en) 2002-06-11 2002-06-11 Vaccine
GB0213364.3 2002-06-11
GB0221689.3 2002-09-18
GB0221689A GB0221689D0 (en) 2002-09-18 2002-09-18 Vaccine
PCT/EP2003/006095 WO2003103706A2 (en) 2002-06-11 2003-06-06 Immunogenic compositions

Publications (1)

Publication Number Publication Date
CA2487907A1 true CA2487907A1 (en) 2003-12-18

Family

ID=29738081

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002487907A Abandoned CA2487907A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions comprising a xenogenic prostate protein p501s

Country Status (6)

Country Link
US (1) US20060140965A1 (enExample)
EP (1) EP1511513A2 (enExample)
JP (1) JP2006501166A (enExample)
AU (1) AU2003250828A1 (enExample)
CA (1) CA2487907A1 (enExample)
WO (1) WO2003103706A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7901680B2 (en) * 2005-10-19 2011-03-08 Ibc Pharmaceuticals, Inc. Dock-and-lock (DNL) vaccines for cancer therapy
WO2006101503A2 (en) * 2004-06-15 2006-09-28 Centocor, Inc. Method for screening agents against human prostate disease
WO2007002149A2 (en) 2005-06-21 2007-01-04 Cyto Pulse Sciences, Inc. Methods and compositions relating to a vaccine against prostate cancer
KR20250121449A (ko) 2017-03-10 2025-08-12 볼트 쓰레즈, 인크. 재조합 단백질을 고분비 수율로 생산하기 위한 조성물 및 방법
EP3592800A4 (en) * 2017-03-10 2021-01-06 Bolt Threads, Inc. COMPOSITIONS AND METHODS OF PRODUCING HIGHLY SECRETED YIELD OF RECOMBINANT PROTEIN

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046769A1 (en) * 1997-04-11 1998-10-22 Dendreon Corporation Composition and method for inducing an immune response against tumour-related antigens
EP1071333A4 (en) * 1998-03-20 2005-02-23 Genzyme Corp INDUCTION OF IMMUNITY AGAINST TUMOR AUTOANTIGENS
TR200100916T2 (enExample) * 1998-07-14 2002-06-21 Corixa@@Corporation
AU7859900A (en) * 1999-10-04 2001-05-10 Corixa Corporation Compositions and methods for wt1 specific immunotherapy
US20020009455A1 (en) * 2000-04-27 2002-01-24 Ted Lau DNA encoding a novel PROST 03 polypeptide

Also Published As

Publication number Publication date
AU2003250828A8 (en) 2003-12-22
WO2003103706A3 (en) 2004-02-19
JP2006501166A (ja) 2006-01-12
US20060140965A1 (en) 2006-06-29
EP1511513A2 (en) 2005-03-09
AU2003250828A1 (en) 2003-12-22
WO2003103706A2 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
AU2019290127B2 (en) Neoantigens and uses thereof
EP1511768B1 (en) Immunogenic compositions
JP4130359B2 (ja) Ｗｔ１特異的免疫療法のための組成物および方法
TWI434697B (zh) 疫苗
US20020039573A1 (en) Compounds and methods for prevention and treatment of HER-2/neu associated malignancies
NZ545948A (en) Improvements in vaccination
EP1420821B1 (en) Immunologically significant herpes simplex virus antigens and methods for using same
CA2401070A1 (en) Compositions and methods for diagnosis and therapy of malignant mesothelioma
EP1320602A2 (en) Spas-1 cancer antigen
US20060140965A1 (en) Immunogenic compositions comprising a xenogenic prostate protein p501s
CA2378846A1 (en) Prostase vaccine
US10316072B2 (en) Immune modulator for immunotherapy and vaccine formulation
CA2584321A1 (en) Combination of a recombinant mycobacterium comprising a nucleic acid encoding a phagolysosomal escape peptide and an immune response eliciting biologically active agent
US20070042047A1 (en) Vaccines
US20030143240A1 (en) Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen
JP2004501638A (ja) 誘導体化されたチオール残基を含むプロスターゼタンパク質ワクチンおよび同抗原の製造方法
JP2007524352A (ja) 上皮細胞ムチンｍｕｃ−１から誘導されるワクチン
WO2002000708A2 (en) Mutants of prostase
HK1074846B (en) Immunogenic compositions
HK1106929B (zh) 作为疫苗的重组分枝杆菌和生物活性剂的组合
ZA200409863B (en) Immunogenic compositions

Legal Events

Date Code Title Description
FZDE Discontinued